Jump to page content

Search results

  • Press release Corona

    The fatal role of T cells in COVID-19

    Scientists from the Berlin Institute of Health at Charité (BIH), together with colleagues from Charité – Universitätsmedizin Berlin and the university hospitals in Bonn and Aachen, have found a type of immune cells that is particularly active in severely ill COVID-19 patients. The CD16 positive T cells have an increased cytotoxic effect, especially…

  • Press release Corona

    Multicenter CATCOVID trial for treating severe COVID-19 progression enrolls first patient

    The clinical phase II trial CATCOVID initiated by the Berlin Institute of Health at Charité (BIH) has cleared the final regulatory hurdles with the receipt of a positive ethics committee vote and with approval from the Federal Institute for Drugs and Medical Devices (BfArM), enrolling its first patient this week at University of Leipzig Medical…

  • Press release Digital Labs

    One million euros for histology in 3D

    Scientists at the Berlin Institute of Health at Charité (BIH) and Charité – Universitätsmedizin Berlin have developed an automatable method for the histological examination of three-dimensional tissue preparations. Their idea could revolutionize microscopic tissue examinations and ease the burden on pathologists. The three founders of the project…

  • Press release Innovations Digital Labs

    Improved patient care through innovations from Israel – first collaboration projects will start in early 2022

    The International Health-Tech Pilot Program promotes forward-looking healthcare solutions from Israel. Now, the first collaboration agreements between Israeli start-up companies, Charité-Universitätsmedizin Berlin, the Berlin Institute of Health at Charité (BIH) and the Israel Innovation Authority have been successfully concluded. The collaboration…

  • Press release Corona

    Are we prepared for the next pandemic? BIH and Tagesspiegel jointly hosted the Future Medicine Round Table in early November

    The SARS-CoV-2 coronavirus has had us in its grip for almost two years. Scientists have accomplished a great deal during this time: They have decoded the virus’s genome, developed tests and vaccines, and investigated how the virus takes hold in the body and spreads from person to person. Yet despite all this knowledge, the end is still not in…

  • Press release Corona

    The aftershock of the COVID-19 pandemic and genomic data for global human health: The BIH hosts panel discussions at the World Health Summit

    Although all the world has been focusing on vaccinations, infection rates and ICU occupancy levels, BIH scientists believe the real big wave is still coming: Long COVID. The patients who successfully survived COVID-19 but are still suffering from long-term effects will in all likelihood continue to present a challenge to the healthcare system for a…

  • Press release Corona

    Strong antiviral immunity in the upper airways protects children from severe COVID-19

    Children can also be infected with the novel coronavirus SARS-CoV-2, but have a substantially lower risk for developing severe COVID-19 disease compared to adults. A team of scientists from the Berlin Institute of Health at Charité (BIH), Charité – Universitätsmedizin Berlin, University of Leipzig Medical Center, and the German Cancer Research…

  • Press release Neurology

    European recognition for digital brain research

    EBRAINS is a digital research infrastructure, created by the EU-funded Human Brain Project, that aims to digitally explore and decode the human brain. Now, after a highly competitive selection process, EBRAINS has been included in the 2021 Roadmap of the European Strategy Forum on Research Infrastructures (ESFRI), laying the foundation for…

  • Press release Corona

    Even the vaccinated benefit from the new and improved CovApp 2.0

    Back in March 2020, Charité joined forces with the Potsdam-based nonprofit organization Data4Life to develop CovApp, which allows users to fill out a questionnaire, determine their personal risk of being infected with the SARS-CoV-2 coronavirus, and receive recommendations for the next steps to take. Now, a participant in the BIH Biomedical…

Press contact

Dr. Stefanie Seltmann

Head of Communications, Press Spokesperson

Contact information
Phone:+49 30 450 543 019
E-mail:stefanie.seltmann@bih-charite.de